Questão de Língua Inglesa

Read the text below to answer questions 18, 19 and 20. Innovation: Glucose Contact Lense On Monday, Google Inc. stated that its health-care research unit reached an agreement to work with European pharmaceutical major Sanofi SA on new ways to treat and monitor diabetes. The Wall Street Journal has the story: Sanofi is a leading maker of diabetes medication, as well as many other drugs. Google’s Life Sciences division is working on small, connected medical devices to continuously collect diabetes-related data, as well as software that learns from the information to find new treatments. Diabetes is expected to affect 592 million people world-wide by 2035, according to the International Diabetes Federation. Google Life Sciences, led by Andrew Conrad, started about two years ago as part of the company’s ambitious goal to expand beyond its Internet search roots into big industries such as health care and transportation. Some of these efforts have stumbled, but Google Life Sciences has made steady progress through in-house research and partnerships with companies such as Novartis AG and Biogen Inc. The life-sciences division will become a stand-alone unit in Google’s planned reorganization into a holding company called Alphabet Inc. Some of the coolest sci-fi sounding developments in store? A Google-designed contact lens that measures the glucose level in tears of diabetics, as well as a cheap, disposable device the size of a Band-Aid to be worn on the skin to send blood-sugar measurements to a smartphone. Adapted from: <https://dailyreckoning.com>. Access: July 27th, 2017.